JSC
BIO icon

Jackson Square Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Jackson Square Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-36
Closed -$19K – 171
2020
Q3 		$19K Buy
36
+23
+177% +$11.7K 0.01% 226
2020
Q2 		$6K Hold
13
– – ﹤0.01% 263
2020
Q1 		$5K Hold
13
– – ﹤0.01% 257
2019
Q4 		$5K Buy
+13
New +$4.58K ﹤0.01% 300

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jackson Square Capital's BIO Position: Q4 2020 in Review

Jackson Square Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2020, closing a stake of 36 shares — an estimated $19K sold.

Jackson Square Capital first reported a position in BIO in Q4 2019 and held it in 4 quarters. The position peaked at $19K in Q3 2020. 491 funds tracked by Wall St. Rank hold BIO as of Q4 2020.

  • Jackson Square Capital reported no remaining Bio-Rad Laboratories Class A position as of Q4 2020 after selling out during the quarter.
  • Jackson Square Capital sold 36 Bio-Rad Laboratories Class A shares in Q4 2020, an estimated $19K.
  • Jackson Square Capital first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 4 quarters.
  • Jackson Square Capital's Bio-Rad Laboratories Class A position peaked at $19K in Q3 2020.
  • 491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2020.

Based on Jackson Square Capital's 13F filing for Q4 2020, filed 5 Mar 2021.